Multivariate Analysis of Factors Influencing Recovery from Hemorrhagic Cystitis after Allo-HSCT.
10.7534/j.issn.1009-2137.2019.03.055
- Author:
Bing ZHANG
1
;
Chen-Yuan HU
1
;
Di YU
1
;
Huan-Xin ZHANG
1
;
Dong-Mei YAN
1
;
Wei SANG
1
;
Zhen-Yu LI
1
;
Zhi-Ling YAN
2
,
3
;
Kai-Lin XU
3
,
4
Author Information
1. Institute of Hematology, Xuzhou Medical University, Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China.
2. Institute of Hematology, Xuzhou Medical University, Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China E-mail: hematology-md@
3. com.
4. Institute of Hematology, Xuzhou Medical University, Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province, China E-mail: lihmd@
- Publication Type:Journal Article
- MeSH:
Cystitis;
Graft vs Host Disease;
Hematopoietic Stem Cell Transplantation;
Humans;
Multivariate Analysis;
Retrospective Studies;
Risk Factors
- From:
Journal of Experimental Hematology
2019;27(3):976-982
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the incidence of hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation and the factors affecting HC, so as to provide clinical evidence for further treatment of HC.
METHODS:The HC of 113 patients after allogeneic hematopoietic stem cell transplantation in Affiliated Hospital of Xuzhou Medical University between the years 2014-2016 was analyzed respectively. All cases of HC were divided into HC group and non-HC(control) group. The follow-up time: from preeonditionig day to 180 d after transplantation. The 10 clinical parameters were selected for univariate analysis with COX regression analysis: sex, age (＜25 years and 25 years), primary disease, conditioning regimen with anti-thymoglobulin(ATG), sex-mismatch in recipients, haploidential HSCT, cytomegalovirus (CMV) viremia, EB viremia, graft-versus-host disease (GVHD), and primary disease relapse, the factors significant at the 0.1 level in univariate analysis should be further evaluated by multivariate analysis using a COX regression analysis. The difference was significant at P＜0.05 in multivariate analysis.
RESULTS:The HC occured in 31 of 113 patients (27.4%), with 5 cases of grade I (5.5%), 19 of grade II (16.8%), 5 of grade III (4.4%), and 2 of grade IV (1.8%). The median time of HC onset was 37 days (26-70 d) after transplantation. The median duration of HC was 14 days (5-55d). Univariate analysis showed that conditioning with anti-thymoglobulin (ATG) (RR=6.170, 95%CI: 1.875-20.306, P＜0.01), CMV viremia (RR=7.633, 95%CI：2.318-25.133) (P＜0.01), haploidentical HSCT (RR=0.307, 95%CI：0.137-0.686, P＜0.01), GVHD (RR=1.891, 95%CI：0.918-3.898, P＞0.05) were the risk factors for recovery from HC. The multivatiate analysis of above-mentioned risk factors with statistical significance showed that only CMV viremia (RR=4.770, 95%CI: 1.394-16.326, P＜0.05) was the indentified risk factor affecting the recovery from HC.
CONCLUSION:Monitoring CMV viremia and antivirotic treatment are effective measurs to prevent the occurrence of HC and promote the recovery from HC.
